|J Roberto Trujillo, M.D., Sc.D.|
J Roberto Trujillo, M.D., Sc.D.
Dr. J. Roberto Trujillo is currently a Director of Latin America Research in Virology and Neurosciences, Head of the Laboratory of Neurovirology and Assistant Professor at the Institute of Human Virology at the University of Maryland School of Medicine. Besides his primary appointments at the University of Maryland, Dr. Trujillo is an Adjunct Professor in Medical Sciences at the University Autonomous of Nuevo Leon, an Honorary Professor at the University autonomous of Mexico State, a Visiting Professor at the University Autonomous of Guadalajara, and a Visiting Professor of Neurovirology in the Department of Neurology at the Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City. He was the First President and Founder of the Pan-American Society for Neurovirology (2000). From 1989 to 2002, Dr Trujillo was an investigator of Neurovirology and Retrovirus at Harvard University. From 2002-2005, he was an Intramural Investigator at the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA.
After graduating from Arts and Sciences State of Mexico College with Summa Cum Laude honors, he received his medical degree from University Autonomous of Mexico State with Summa Cum Laude honors as well. Following an internship in medicine, he spent two years as a clinical neuroscience fellow at Baylor College of Medicine, Houston, Texas. Dr. Trujillo was a recipient of a National Research Training Award from NIH under the direction of a Lasker Prize winner Dr. Max Essex, at Harvard University. From 1990 to 1995 he completed his Doctor of Science degree in virology and neuroscience from Harvard University. Following a Post-Doctoral training at Harvard University, Dr. Trujillo served as a Research Associate in Neurovirology and Cell Biology from 1998-2002 at Harvard School of Public Health. He also served as an Instructor of Science in Harvard College (1997-1999).
Dr. Trujillo’s research interests include: molecular basis of neurotropism of HIV-1, viral-immune responses in the nervous system, opportunistic infections of AIDS including neurocysticercosis. Dr. Trujillo’s work has been published in over 40 scientific manuscripts and reviews with more than 50 conference abstracts and book chapters. In addition, Dr. Trujillo has edited 4 multimedia CD-ROMs for scientific meetings including the "3-D Animation Model of HIV-1 Neurotropism", sponsored by the Office of AIDS Research, National Institutes of Health (NIH), US. Dr. Trujillo was the first to report the 'MOLECULAR MIMICRY" between the HIV-1 gp120 V3 loop and human brain proteins. This work was chosen to be the highlight paper by the American Society of Microbiology. In addition, this work was chosen as a paper of the year by Harvard School of Public Health (1994). He has since then shown that using viral molecular mimicry can induce killing of cancer brain cells. Dr. Trujillo, along with Dr. Essex at Harvard University, has also shown for the first time the molecular determinant of HIV-1 neurotropism. Recently Dr. Trujillo identified that a MR-mediated pathway does not elicit a productive HIV-I infection in macrophages, microglia and astrocytes. This paper appeared at the Proceedings of the National Academy of Sciences (2007). Such insight may foster new HIV-I vaccine design and an improve understanding of HIV-I/AIDS pathogenesis.
As a pioneer in medical-sciences in the Americas, he helped to build the first BL-3 laboratory in Mexico (1998), the Health Science Center in Monterrey, Mexico (2005- ), and currently, he is directing the development of a new Medical Science Center in Guadalajara Mexico. In addition, he has created exchange MD/Ph.D, Postdoctoral, and Professor Programs between US Institutions and Mexico, including at Harvard University, National Institutes of Health US, and at the University of Maryland. As a pioneer in neurovirology, he has developed cutting-edge research programs across the Americas countries; he has chaired more the 20 international meetings including two Pan-American Symposiums; and organized offices for the Pan-American Society of Neurovirology in Mexico, Brazil and currently in US.
He has received numerous awards for his work, including the Ruth L. Kirschstein National Research Service Award; Helena Rubinstein Award at Harvard University, the National Research NIH Training Award; the outstanding Professor of Neurovirology by the Pan-American Society of Neurology, the outstanding Professional of Science in Mexico; and twice received the "Key of the City" in Mexico. In addition, Dr. Trujillo received the pioneer award in Neurovirology in Spain, and recently he has been recognized as the 100 most influential Professional Mexicans in US. Dr. Trujillo has given numerous lectures around the world in the field of Neurovirology and NeuroAIDS including United States, Mexico, Canada, France, Italy, The Netherlands, Japan, Germany, Morocco, Scotland, Republic of Botswana, Spain, Puerto Rico, Colombia, Brazil, and Nigeria. He sits in several consulting and scientific editorial boards. These includes the Ad Hoc Reviewer of the Department of Health and Human Services, Office of AIDS Research, NIH, US; Ad Hoc Reviewer of the World Bank; Ad Hoc Reviewer, National Institute of Child Health and Human Development, NIH, and currently he is a Permanent Member for Microbiology and Infectious Diseases Research Committee at the National Institute of Allergy and Infectious Diseases, NIH, US.